GBG Forschungs GmbH is an independent institute dedicated to breast cancer research. We strive to develop more effective therapies that increase the chances of a cure for breast cancer patients as well as improving their quality of life. Together with the German Breast Group, an academic study group, we conduct clinical and academic studies in accordance with the highest international standards.
Our philosophy:
Healing through innovation, expertise and partnership.
Our clinical trials investigating the efficacy of breast cancer therapies cover all stages and types of the disease. Around 800 study centers and more than 1,000 trial investigators are involved worldwide.
In addition, we also address other important research questions, such as breast cancer in pregnancy or breast cancer with brain metastases.
This enables us to provide clinicians with knowledge for treating rare cases of breast cancer. We also conduct research into preventive strategies for women with a high risk of contracting the disease.
Independant, academic, neutral
When conducting our breast cancer research projects, we adhere to the recognized guidelines of international academic study groups. The study designs are developed by the members of our various subboards.
Once the studies have been carried out by GBG Forschungs GmbH, the results are analyzed by the subboard members and published independently of third-party interests.
As an impartial Academic Research Organization (ARO), we do not undertake pure contract research without academic involvement.
Competent, experienced, international
Today, GBG Forschungs GmbH has clinical data from more than 67,000 breast cancer patients at its disposal. Thanks to our expertise and experience gained from over 20 years of research and 115 studies, we are one of the world’s leading breast cancer research institutes. We are constantly expanding our knowledge in close cooperation with national and international study groups as well as leading pharmaceutical manufacturers.
Founded in 2003, GBG Forschungs GmbH provides the legal and operational platform for the studies of the German Breast Group academic study group. This enables us to provide a professional infrastructure for clinical research and to meet the complex legal requirements.
The academic-cooperative study group German Breast Group comprises more than 1.000 physicians in around 800 study centers. In five working groups, the so-called subboards, scientists of the German Breast Group develop innovative concepts and ideas for new study and research projects together with a large number of proven German breast cancer experts. During the course, the external subboard members accompany the study project scientifically and at the same time monitor the safety of the study participants.
Here you will find our internationally renowned breast cancer experts:
The Subboard Adjuvant Studies develops study concepts for the adjuvant therapy phase.
Prof. Dr. Carsten Denkert, Marburg
Prof. Dr. Wolfgang Janni, Ulm
Prof. Dr. med. Sibylle Loibl, Neu-Isenburg
Prof. Dr. Frederik Marmé, Mannheim
Dr. med. Laura Michel, Heidelberg
Prof. Dr. med. Toralf Reimer, Rostock
PD Dr. med. Mattea Reinisch, Essen
Dr. med. Sabine Schmatloch, Kassel
Prof. Dr. med. Marcus Schmidt, Mainz
Dr. med. Bruno Sinn, Berlin
Prof. Dr. med. Elmar Stickeler, Aachen
Prof. Dr. med. Michael Untch, Berlin
The Subboard Neoadjuvant Studies develops study concepts for the neoadjuvant therapy phase.
Prof. Dr. Jens-Uwe Blohmer, Berlin
Prof. Dr. Carsten Denkert, Marburg
Prof. Dr. med. Peter A. Fasching, Erlangen
Dr. med. Claus Hanusch, München
Prof. Dr. Jens Huober, St. Gallen
Prof. Dr. med. Christian Jackisch, Offenbach
Dr. med. Theresa Link, Dresden
Prof. Dr. med. Sibylle Loibl, Neu-Isenburg
PD Dr. med. Mattea Reinisch, Essen
Prof. Dr. Kerstin Rhiem, Köln
Prof. Dr. med. Andreas Schneeweiß, Heidelberg
Prof. Dr. med. Christine Solbach, Frankfurt
Prof. Dr. med. Michael Untch, Berlin
Univ.-Prof. Dr. Med. Andreas Hartkopf, Tübingen
Prof. Vesna Bjelic-Radisic, Witten-Herdecke
The Subboard Locoregional/Operative Studies Subboard develops study concepts for operational research.
PD Dr. med. Beyhan Ataseven, Lippe
Prof. Dr. Carsten Denkert, Marburg
Prof. Dr. med. habil. Bernd Gerber, Rostock
Prof. Dr. med. Michael Golatta, Heidelberg
Prof. Dr. med. Markus Hahn, Tübingen
Prof. Dr. med. Jörg Heil, Heidelberg
PD Dr. David Krug, Kiel
Prof. Dr. Thorsten Kühn, Esslingen
Prof. Dr. med. Sibylle Loibl, Neu-Isenburg
PD Dr. Inga Bekes, St. Gallen
The Subboard Palliative Studies develops study concepts for the metastatic therapy phase.
Prof. Dr. med. Thomas Decker, Ravensburg
Prof. Dr. Carsten Denkert, Marburg
Prof. Dr. med. Sibylle Loibl, Neu-Isenburg
Dr. med. Kristina Lübbe, Hannover
Prof. Dr. med. Volkmar Müller, Hamburg
Prof. Dr. med. Christoph Mundhenke, Bayreuth
Prof. Dr. med. Marcus Schmidt, Mainz
Prof. Dr. med. Marc Thill, Frankfurt
The Subboard Translational Research develops study concepts for translational research.
Prof. Dr. Carsten Denkert, Marburg
Prof. Dr. med. Peter A. Fasching, Erlangen
Prof. Dr. phil. Nat. Thomas Karn, Frankfurt
Prof. Dr. med. Sibylle Loibl, Neu-Isenburg
Prof. Dr. Frederik Marmé, Mannheim
Prof. Dr. med. Volkmar Müller, Hamburg
Prof. Dr. med. Christian Schem, Hamburg
PD Dr. med. Bruno Sinn, Berlin
Prof. Dr. med. Elmar Stickeler, Aachen
PD Dr. med. Marion van Mackelenbergh, Kiel
The funding of our research is project-related. On the one hand, we receive public funding, e.g. from the Deutschen Krebshilfe, the Deutschen Forschungsgemeinschaft, the Bundesministerium für Bildung und Forschung(BMBF). On the other hand, private foundations also support us financially. Therapeutic drug studies are mostly provided by the researching drug companies. Our area of translational basic research is predominantly supported by public funds from the EU and the federal government, as well as by various foundation funds.
The founders of the German Breast Group are now honorary members of the study group.
Prof. Dr. Walter Jonat
Prof. Dr. Manfred Kaufmann
Prof. Dr. Fred Kubli
Prof. Dr. Wolfgang Eiermann
Prof. Dr. Jörn Hilfrich
Dr. Bettina Conrad
Prof. Dr. Nicolai Maass
Dr. Holger Eidtmann
Annual scientific reports
Our Annual Scientific Reports provide a condensed overview of the results of our ongoing studies, important scientific lectures and research posters. They also describe the organizational structure and research activities of the GBG.
